A STUDY TO ASSESS THE EFFECTIVENESS OF POMEGRANATE JUICE ON BLOOD PRESSURE AMONG HYPERTENSIVE PATIENTS ADMITTED IN SELECTED HOSPITALS

This study aimed to evaluate the effectiveness of pomegranate juice in reducing blood pressure among hypertensive patients admitted to selected hospitals. The objectives were to assess existing blood pressure levels, evaluate the effectiveness of pomegranate juice, and compare pre-test and post-test scores among experimental groups. The hypothesis tested whether pomegranate juice significantly affects blood pressure. A quantitative evaluative approach with a two-group pre-test post-test design was employed, involving 40 hypertensive patients selected through non-probability purposive sampling. The experimental group received 200ml of pomegranate juice daily for 5 days, while the control group received routine treatment. Blood pressure was measured using a sphygmomanometer and stethoscope. Results showed a significant reduction in both systolic and diastolic blood pressure in the experimental group, with mean systolic pressure decreasing from 169 mmHg to 118 mmHg and mean diastolic pressure from 99.5 mmHg to 79.5 mmHg. The control group showed no significant changes. The study concluded that pomegranate juice is an effective, cost-efficient, and palatable alternative treatment for reducing blood pressure in hypertensive patients, complementing pharmacological therapy. Further studies with larger sample sizes and longer durations are recommended to validate these findings and explore comparisons with other complementary therapies.